ANSBERT GADICKE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ANSBERT GADICKE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ANSBERT GADICKE. ANSBERT GADICKE is a 10% Owner in RIGEL PHARMACEUTICALS INC ($RIGL) and a Director in CHIASMA, INC ($CHMA) and a Director in Radius Health, Inc. ($RDUS) and a 10% Owner in Harpoon Therapeutics, Inc. ($HARP) and a Director in Allovir, Inc. ($ALVR) and a Director in TCR2 THERAPEUTICS INC. ($TCRR) and a 10% Owner in Werewolf Therapeutics, Inc. ($HOWL) and a 10% Owner in iTeos Therapeutics, Inc. ($ITOS) and a Director in iTeos Therapeutics, Inc. ($ITOS) and a 10% Owner in Repare Therapeutics Inc. ($RPTX) and a Director in Cullinan Management, Inc. ($CGEM).
Address: C/O MPM ASSET MANAGEMENT 111 HUNTINGTON AVENUE, 31ST FLOOR BOSTON 02199 MA
Companies in which ANSBERT GADICKE is an Insider
Allovir, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ANSBERT GADICKE: Director
Holdings: 13,420,970 shares
Latest Transaction: Aug 05 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CHIASMA, INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ANSBERT GADICKE: Director
Holdings: 5,681,544 shares
Current Value: $10,226,779
Latest Transaction: Jun 13 2016
$CHMA Market Capitalization: $43.85M
$CHMA Previous Close: $1.80
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Cullinan Oncology, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ANSBERT GADICKE: Director
Holdings: 281,268 shares
Latest Transaction: Jan 14 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Harpoon Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ANSBERT GADICKE: 10% Owner
Holdings: 6,407,748 shares
Latest Transaction: May 24 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
iTeos Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ANSBERT GADICKE: 10% Owner, Director
Holdings: 6,004,368 shares
Latest Transaction: Apr 13 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Radius Health, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ANSBERT GADICKE: Director
Holdings: 3,887,502 shares
Current Value: $162,730,834
Latest Transaction: Feb 22 2017
$RDUS Market Capitalization: $1.86B
$RDUS Previous Close: $41.86
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Repare Therapeutics Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ANSBERT GADICKE: 10% Owner
Holdings: 4,223,930 shares
Latest Transaction: Jun 02 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
RIGEL PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ANSBERT GADICKE: 10% Owner
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jul 07 2004
$RIGL Market Capitalization: $237.45M
$RIGL Previous Close: $2.45
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
TCR2 THERAPEUTICS INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ANSBERT GADICKE: Director
Holdings: 79,644 shares
Latest Transaction: Feb 21 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Werewolf Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ANSBERT GADICKE: 10% Owner
Holdings: 4,939,150 shares
Latest Transaction: May 06 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of ANSBERT GADICKE
Sentiment: All, ALVR, CHMA, CGEM, HARP, ITOS, RDUS, RPTX, RIGL, TCRR, HOWL
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 02 2021 | RPTX | Repare Therapeutic ... | GADICKE ANSBERT | 10% Owner | Sell | S | 32.42 | 297 | 9,629 | 4,202,574 | 4.2 M to 4.2 M (-0.01 %) |
| Jun 02 2021 | RPTX | Repare Therapeutic ... | GADICKE ANSBERT | 10% Owner | Sell | S | 31.83 | 5,918 | 188,370 | 4,202,871 | 4.2 M to 4.2 M (-0.14 %) |
| Jun 02 2021 | RPTX | Repare Therapeutic ... | GADICKE ANSBERT | 10% Owner | Sell | S | 32.50 | 15,141 | 492,083 | 4,208,789 | 4.2 M to 4.2 M (-0.36 %) |
| Jun 02 2021 | RPTX | Repare Therapeutic ... | GADICKE ANSBERT | 10% Owner | Sell | S | 32.67 | 16,742 | 546,961 | 4,223,930 | 4.2 M to 4.2 M (-0.39 %) |
| May 24 2021 | RPTX | Repare Therapeutic ... | GADICKE ANSBERT | 10% Owner | Sell | S | 34.28 | 18,653 | 639,425 | 4,279,231 | 4.3 M to 4.3 M (-0.43 %) |
| May 24 2021 | RPTX | Repare Therapeutic ... | GADICKE ANSBERT | 10% Owner | Sell | S | 33.30 | 3,547 | 118,115 | 4,297,884 | 4.3 M to 4.3 M (-0.08 %) |
| May 24 2021 | RPTX | Repare Therapeutic ... | GADICKE ANSBERT | 10% Owner | Sell | S | 34.80 | 302,669 | 10,532,881 | 4,301,431 | 4.6 M to 4.3 M (-6.57 %) |